Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice side effects from Mounjaro within the first few hours of their injection, though some — particularly gastrointestinal symptoms like nausea — can build gradually over the first day or two. The timing varies by individual and by dose. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses your full medical picture before treatment begins, and side-effect timing is something they can prepare you for at that stage.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
For many people, yes. The window is typically within two to six hours of injecting, though this is not universal. Nausea is usually the first thing people notice, sometimes accompanied by burping, indigestion or a feeling of fullness that arrives earlier than expected during meals. Fatigue and mild headache can appear on the same day too.
The reason side effects cluster around injection day comes down to how tirzepatide works. It activates both GIP and GLP-1 receptors, slowing gastric emptying and signalling fullness to the brain. That slowing effect on the gut is also what drives the nausea. The NHS tirzepatide medicines page sets out the full list of known effects and their relative frequency, and it is worth reading before your first pen.
Not everyone reacts on the first day. Some people sail through the 2.5mg starter period with almost no symptoms, then find the step to 5mg harder. Others feel nothing until their second or third weekly injection. The pattern is genuinely variable, which is part of why having a prescriber to contact matters. Our Mounjaro injection guide covers what to expect week by week during the early doses.
If you are wondering how long after a Mounjaro injection you feel effects, for most people the worst of the gastrointestinal symptoms peaks within one to three days and then eases. By the end of the first week the body has largely adapted, and symptoms are noticeably lighter ahead of the next dose. That said, some people find the day-one-to-three window uncomfortable enough to affect their routine.
Practical things that tend to help: eating smaller portions, avoiding very fatty or spicy food in the day or two after injecting, staying well hydrated, and giving yourself a little space after meals rather than eating on the move. Some people choose to inject in the evening so any nausea peaks overnight. The pen lives in the fridge door between doses, which makes a consistent injection-day routine easier to build.
The side-effect profile also shifts over time. Weeks one to four on a given dose are typically the hardest; by weeks five to eight most people describe much milder or no symptoms at that strength. A detailed look at the full side-effect picture across doses is on our Mounjaro injection side effects page.
Most side effects are manageable and temporary. A few are not, and it is important to know the difference before you inject for the first time.
Seek urgent medical help if you develop severe stomach pain that does not ease, especially pain that spreads towards the back, with or without vomiting. This can be a sign of pancreatitis. The MHRA issued a formal Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, if infrequent, serious risk with GLP-1 medicines; the update is searchable at gov.uk/drug-safety-update.
Also contact a clinician or call 111 if you experience signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing), symptoms of gallbladder problems (sudden pain in the upper-right abdomen), significant dehydration from repeated vomiting or diarrhoea, or any new low mood or thoughts of self-harm.
For suspected side effects that are not emergencies, the Yellow Card scheme allows patients to report directly to the MHRA. This surveillance data genuinely shapes how the regulator monitors medicines like tirzepatide over time.
If you are uncertain whether a symptom warrants medical attention, our prescribers are reachable seven days a week through aftercare, you do not have to guess alone. You can also find broader context on the side effects of the Mounjaro injection and what distinguishes normal adjustment from something that needs review.
Yes, and this is the question our prescribers hear most often from people several weeks into treatment. Each dose step, 2.5mg to 5mg to 7.5mg and so on, can reset the side-effect clock. The body has adapted to the lower dose; the higher dose is a fresh stimulus. So someone who had no nausea at 2.5mg may experience it meaningfully at 5mg, and that is not a sign something has gone wrong.
The timing pattern stays roughly the same: symptoms within the first day or two of the new dose, easing by the end of the first week, largely settled by weeks three to four. Your prescriber will have reviewed your suitability for the increase before confirming it, and that review is also the moment to flag any concerns about how the previous dose felt.
For a broader look at how tirzepatide works and what the clinical-trial evidence shows, the tirzepatide weight-loss injection overview is a good place to start. And if you are still weighing up whether Mounjaro is the right treatment for you, speaking to our prescribers as part of a free consultation is a reasonable next step, side-effect timing and personal tolerability are exactly the kind of detail they work through with you before a prescription is issued.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.